Creb5 — Camp Responsive Element Binding Protein 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CREB5 encodes a member of the CREB (cAMP response element-binding) family of transcription factors. CREB5 is located on chromosome 7p15.1 and is expressed in brain regions involved in learning and memory. The gene is catalogued as NCBI Gene ID 9586 [1].
The CREB family of transcription factors is evolutionarily conserved and plays critical roles in cellular processes including metabolism, development, and neuroplasticity [2]. CREB5 represents a distinct member of this family with unique expression patterns and functional characteristics that distinguish it from other CREB family members such as CREB (CREB1), ATF1, and CREM [3].
CREB5 is a DNA-binding transcription factor that recognizes CRE (cAMP response element) sequences (TGACGTCA) in the promoter regions of target genes [4]. Like other CREB family members, CREB5 contains a basic leucine zipper (bZIP) domain that facilitates DNA binding and protein dimerization [5].
The transcriptional activity of CREB5 is regulated through multiple mechanisms:
CREB5 is expressed in key brain regions associated with neurodegenerative processes, including the hippocampus, cerebral cortex, and striatum. These brain regions are critically involved in cognitive function, motor control, and memory formation, making them particularly vulnerable to neurodegenerative processes [6].
Research has demonstrated that CREB proteins play essential roles in:
CREB5 activity is modulated by several key signaling pathways:
These signaling pathways integrate various extracellular and intracellular signals to coordinate appropriate transcriptional responses in neurons [7].
CREB5 has been implicated in Alzheimer's disease (AD) pathogenesis through multiple mechanisms. Research indicates that CREB-mediated transcription is dysregulated in AD, contributing to impaired synaptic plasticity and memory deficits [8]. Studies have shown that:
The hippocampus, a brain region critical for memory formation, shows particularly significant CREB dysregulation in AD. Research has demonstrated that restoring CREB function may have therapeutic potential in AD treatment [9].
In Parkinson's disease (PD), CREB5 plays a role in protecting dopaminergic neurons from degeneration. Studies have shown that:
Research indicates that CREB5 activation may represent a therapeutic strategy for PD, as it can promote the expression of neurotrophic factors and anti-oxidant genes [10].
CREB5 dysfunction is particularly relevant to Huntington's disease (HD), a neurodegenerative disorder caused by mutant huntingtin protein. Studies have revealed:
The striatum, which is particularly affected in HD, shows significant CREB5 dysregulation. Research suggests that CREB5-dependent transcriptional programs are essential for medium spiny neuron survival [11].
The CREB5 gene (ENSG00000101158) is located on chromosome 7p15.1 and encodes a protein of approximately 341 amino acids. The UniProt entry Q8TD36 provides detailed information about the protein structure and functional domains [12].
CREB5 contains several functional domains:
Genetic variations in CREB5 have been studied in the context of neurodegenerative diseases. Several single nucleotide polymorphisms (SNPs) in the CREB5 gene region have been associated with altered disease risk or progression in various populations.
CREB5 represents a promising therapeutic target for neurodegenerative diseases. Strategies being explored include:
CREB5 expression levels and phosphorylation status may serve as biomarkers for:
CREB5 interacts with and is functionally related to several other proteins and pathways:
CREB5 (cAMP Responsive Element Binding Protein 5) is a transcription factor encoded by the gene located at 7p15.1. It plays critical roles in neuronal function and survival, with particular relevance to neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease. The protein participates in key signaling pathways that regulate gene expression programs essential for synaptic plasticity, neuronal survival, and metabolic regulation. Understanding CREB5 function and dysfunction in neurodegenerative contexts provides insights into disease mechanisms and potential therapeutic interventions.
The study of Creb5 — Camp Responsive Element Binding Protein 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See also:
Page expanded with research content. Last updated: 2026-03-07T11:20:55.509431+00:00